Condition

Plasmablastic Lymphoma clinical trials and research

• 8Clinical trials
• 8Countries

Newest Plasmablastic Lymphoma clinical trials

All recruiting trials (8)

• Glofitamab with R-CHOP for Newly Diagnosed HIV-Related Large B-Cell Lymphoma

  This phase 1 study tests glofitamab plus R-CHOP chemoimmunotherapy in adults newly diagnosed with HIV-related large B-cell lymphoma to see if the regimen is safe and tolerable.

  Recruiting Phase 1 National Cancer Institute (NCI) · Rockville, Maryland · NCT07649304

• Elranatamab consolidation for newly diagnosed plasmablastic lymphoma

  This study tests whether giving Elranatamab after initial chemotherapy can help patients with plasmablastic lymphoma, with or without HIV, stay in remission.

  Recruiting Phase 1 University of Illinois Chicago · Chicago, Illinois · NCT07647432

• Collecting data on patients with plasmablastic lymphoma

  This study is collecting information from patients with plasmablastic lymphoma to better understand their treatment, outcomes, and the disease itself.

  Recruiting at 14 sites Fondazione Italiana Linfomi - ETS · Aviano, PN and 22 other locations · NCT06781359

• Collecting blood and tissue samples for HIV/AIDS-related cancer research

  This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.

  Recruiting at 8 sites AIDS Malignancy Consortium · La Jolla, California and 7 other locations · NCT05663502

• Evaluating SGR-1505 for treating mature B-cell neoplasms

  This study is testing a new oral medication called SGR-1505 to see if it is safe and effective for people with certain types of B-cell lymphomas that have not responded to other treatments.

  Recruiting at 36 sites Phase 1 Schrödinger, Inc. · Gilbert, Arizona and 35 other locations · NCT05544019

• Combining Pomalidomide with Chemotherapy for HIV-Related Lymphomas

  This study is testing if adding a drug called pomalidomide to chemotherapy can help adults with HIV-related lymphomas feel better and improve their treatment outcomes.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05389423

• Evaluating a treatment combining Daratumumab, Bortezomib, and Dexamethasone for Plasmablastic Lymphoma

  This study is testing a new combination treatment of Daratumumab, Bortezomib, and Dexamethasone to see if it helps people with relapsed or hard-to-treat Plasmablastic Lymphoma.

  Recruiting at 14 sites Phase 2 Fondazione Italiana Linfomi - ETS · Ancona, Ancona and 17 other locations · NCT04915248

• Daratumumab plus dose-adjusted EPOCH for plasmablastic lymphoma

  This treatment tries adding the antibody daratumumab to DA-EPOCH chemotherapy to see if it helps people with newly diagnosed stage I–IV plasmablastic lymphoma.

  Recruiting at 9 sites Early Phase 1 AIDS Malignancy Consortium · Miami, Florida and 8 other locations · NCT04139304

Related topics

Quick answers

How many Plasmablastic Lymphoma clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United States (6 trials), Italy (3 trials), France (1 trial), Moldova (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Phase 2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →